45 related articles for article (PubMed ID: 9233528)
1. Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy.
Bower M; Newlands ES; Holden L; Rustin GJ; Begent RH
Ann Oncol; 1997 May; 8(5):477-83. PubMed ID: 9233528
[TBL] [Abstract][Full Text] [Related]
2. Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.
Bührer E; D'Haese D; Daugaard G; de Wit R; Albany C; Tryakin A; Fizazi K; Stahl O; Gietema JA; De Giorgi U; Cafferty FH; Hansen AR; Tandstad T; Huddart RA; Necchi A; Sweeney CJ; Garcia-Del-Muro X; Heng DYC; Lorch A; Chovanec M; Winquist E; Grimison P; Feldman DR; Terbuch A; Hentrich M; Bokemeyer C; Negaard H; Fankhauser C; Shamash J; Vaughn DJ; Sternberg CN; Heidenreich A; Collette L; Gillessen S; Beyer J
Eur J Cancer; 2024 May; 202():114042. PubMed ID: 38564927
[TBL] [Abstract][Full Text] [Related]
3. Disease characteristics and survival outcomes of extragonadal primary germ cell tumour in two Canadian tertiary cancer centres.
Ko JJ; Asif T; Li H; Alimohamed N; Nguyen PT; Heng DY
Can Urol Assoc J; 2016; 10(5-6):E165-E170. PubMed ID: 27790297
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of a high-risk nonseminomatous germ cell tumor using etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine: A case report.
Yun J; Lee SW; Lim SH; Kim SH; Kim CK; Park SK
World J Clin Cases; 2020 Nov; 8(21):5334-5340. PubMed ID: 33269267
[TBL] [Abstract][Full Text] [Related]
5. Imaging features of brain metastases from testicular cancer:
Pinto AF; Silva SM; Carneiro E; Ferreira D; Maurício J; Arantes M
Porto Biomed J; 2017; 2(5):223-224. PubMed ID: 32258724
[No Abstract] [Full Text] [Related]
6. Is CBOP/BEP an alternative to BEP for patients with poor prognosis metastatic germ cell tumours?
Addeo A; Fusco V; Braybrooke JP
ESMO Open; 2016; 1(4):e000089. PubMed ID: 27843634
[No Abstract] [Full Text] [Related]
7. Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration.
Olson TA; Murray MJ; Rodriguez-Galindo C; Nicholson JC; Billmire DF; Krailo MD; Dang HM; Amatruda JF; Thornton CM; Arul GS; Stoneham SJ; Pashankar F; Stark D; Shaikh F; Gershenson DM; Covens A; Hurteau J; Stenning SP; Feldman DR; Grimison PS; Huddart RA; Sweeney C; Powles T; Lopes LF; dos Santos Agular S; Chinnaswamy G; Khaleel S; Abouelnaga S; Hale JP; Frazier AL
J Clin Oncol; 2015 Sep; 33(27):3018-28. PubMed ID: 26304902
[TBL] [Abstract][Full Text] [Related]
8. A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604).
Huddart RA; Gabe R; Cafferty FH; Pollock P; White JD; Shamash J; Cullen MH; Stenning SP; ;
Eur Urol; 2015 Mar; 67(3):534-43. PubMed ID: 25001888
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and efficacy of different chemotherapeutic regimens in patients with mediastinal nonseminomatous germ cell tumors.
Fedyanin M; Tryakin A; Mosyakova Y; Pokataev I; Bulanov A; Zakharova T; Polockii B; Garin A; Tjulandin S
J Cancer Res Clin Oncol; 2014 Feb; 140(2):311-8. PubMed ID: 24337455
[TBL] [Abstract][Full Text] [Related]
10. Survival from testicular cancer in England and Wales up to 2001.
Huddart RA
Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S83-5. PubMed ID: 18813271
[No Abstract] [Full Text] [Related]
11. A decision-analytic approach to define poor prognosis patients: a case study for non-seminomatous germ cell cancer patients.
van Dijk MR; Steyerberg EW; Habbema JD
BMC Med Inform Decis Mak; 2008 Jan; 8():1. PubMed ID: 18171485
[TBL] [Abstract][Full Text] [Related]
12. GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours.
Shamash J; Powles T; Ansell W; Berney D; Stebbing J; Mutsvangwa K; Wilson P; Asterling S; Liu S; Wyatt P; Joel SP; Oliver RT
Br J Cancer; 2007 Aug; 97(3):308-14. PubMed ID: 17609665
[TBL] [Abstract][Full Text] [Related]
13. Testicular choriocarcinoma metastatic to the skin.
Sofikerim M; Doğan I; Ekici S; Bayraktar N; Ozen H
Int Urol Nephrol; 2005; 37(4):759-62. PubMed ID: 16362594
[TBL] [Abstract][Full Text] [Related]
14. Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948).
Fosså SD; Paluchowska B; Horwich A; Kaiser G; de Mulder PH; Koriakine O; van Oosterom AT; de Prijck L; Collette L; de Wit R;
Br J Cancer; 2005 Nov; 93(11):1209-14. PubMed ID: 16251877
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours.
McNeish IA; Kanfer EJ; Haynes R; Giles C; Harland SJ; Driver D; Rustin GJ; Newlands ES; Seckl MJ
Br J Cancer; 2004 Mar; 90(6):1169-75. PubMed ID: 15026797
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours.
Anthoney DA; McKean MJ; Roberts JT; Hutcheon AW; Graham J; Jones W; Paul J; Kaye SB
Br J Cancer; 2004 Feb; 90(3):601-6. PubMed ID: 14760371
[TBL] [Abstract][Full Text] [Related]
17. Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up study.
Gaffan J; Holden L; Newlands ES; Short D; Fuller S; Begent RH; Rustin GJ; Seckl MJ
Br J Cancer; 2003 Nov; 89(10):1849-54. PubMed ID: 14612891
[TBL] [Abstract][Full Text] [Related]
18. Malignant germ cell tumors metastatic to the brain: a model for a curable neoplasm? The Freiburg experience and a review of the literature.
Lutterbach J; Spetzger U; Bartelt S; Pagenstecher A
J Neurooncol; 2002 Jun; 58(2):147-56. PubMed ID: 12164687
[TBL] [Abstract][Full Text] [Related]
19. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
20. Regular review: Managing testicular cancer.
Dearnaley D; Huddart R; Horwich A
BMJ; 2001 Jun; 322(7302):1583-8. PubMed ID: 11431302
[No Abstract] [Full Text] [Related]
[Next] [New Search]
